HarmonyCares Raises $200 Million to Expand In-Home Primary Care Access Nationwide

HarmonyCares, a trailblazer in value-based in-home primary care, has secured $200 million in funding to extend its innovative care model to more patients across the United States. The investment, led by General Catalyst, McKesson Ventures, and a major national payor, alongside K2 HealthVentures and existing investors, marks a significant step towards addressing the critical gap…

Read More

NeuroBrave’s Breakthrough: Selected for Google’s AI Startup Program and Secures Major Investment

NeuroBrave, a pioneering force in cognitive and emotional technologies aimed at enhancing mental health and wellness solutions globally, has achieved a significant milestone by being selected for Google’s esteemed AI Startups Program and securing investment from the Google AI Fund. This strategic partnership marks a pivotal moment for NeuroBrave as it accelerates the development and…

Read More

Courier Health Secures $16.5 Million Investment to Revolutionize Patient Engagement in Life Sciences

Courier Health, a trailblazing technology firm dedicated to enhancing patient support within the life sciences sector, has announced a significant milestone with the closure of a $16.5 million Series A funding round. Led by Norwest Venture Partners and supported by existing investor Work-Bench, this financing underscores a pivotal moment for the company as it continues…

Read More

AIRS Medical Secures $20M in Series C Funding to Expand AI-Powered Healthcare Solutions

AIRS Medical, a trailblazer in artificial intelligence (AI) and robotics for healthcare applications, has announced a significant milestone with the closing of its Series C funding round, securing $20 million from leading institutional investors in South Korea. BSK Investment and Shinyoung Securities led the investment, underscoring confidence in AIRS Medical’s pioneering efforts to revolutionize preventive…

Read More

Mammha Secures Vital Funding from American Heart Association to Advance Perinatal Mental Health Solutions

Mammha, a pioneering provider of perinatal mental health care solutions, proudly announces a significant funding infusion from the American Heart Association Social Impact Funds. This transformative support, awarded on June 5th, 2024, is poised to propel Mammha’s innovative initiatives aimed at enhancing mental health services for parents and healthcare providers nationwide. The American Heart Association’s…

Read More

Waypoint Bio Launches with $14.5M to Revolutionize Solid Tumor Therapy Through Innovative Drug Discovery Technology

Waypoint Bio, a pioneering biotechnology firm, has secured $14.5 million in seed funding led by Hummingbird Ventures, alongside Recode Ventures and Fifty Years, to advance its cutting-edge approach in developing cell therapies for solid tumors. Founded by MIT alumni Xinchen Wang and David Phizicky, Waypoint Bio harnesses in vivo spatial pooled screening technology to drive…

Read More

RareCyte Secures $20M to Expand Orion™ Spatial Biology Platform and Precision Biology Services

RareCyte, Inc., a pioneering Life Sciences company renowned for its Precision Biology platforms, has announced the successful completion of a $20 million financing round aimed at bolstering its Orion™ Spatial Biology platform. This funding, sourced from a blend of new and existing investors, including Forest Road, Arboretum Ventures, and F-Prime Capital, underscores RareCyte’s commitment to…

Read More

NeOnc Technologies Secures $18.5 Million to Propel Breakthrough Brain Cancer Therapies Through Phase II Trials

NeOnc Technologies Holdings, Inc., a forefront player in clinical-stage biotechnology, has successfully concluded an $18.5 million financing round aimed at advancing its innovative approach to treating brain cancer. This funding milestone includes new equity investment and debt conversions, reflecting a substantial increase in NeOnc’s valuation and reinforcing its commitment to pioneering neurological therapeutics. The financing…

Read More

Augustine Therapeutics Secures EUR 17 Million in Series A Funding to Propel Groundbreaking Neurological Disease Treatment

Augustine Therapeutics, a pioneering biotechnology firm specializing in innovative therapies for neurodegenerative and cardiometabolic diseases, announced a significant milestone today with the successful completion of a EUR 17 million (USD 18.5 million) first closing of its Series A funding round. This financing, led by Asabys Partners and supported by Eli Lilly and Company and the…

Read More

Transformative Health Insurance Innovator Sidecar Health Secures $165M Series D Funding Led by Koch Disruptive Technologies

Sidecar Health, a pioneering force in revolutionizing health insurance accessibility and transparency, proudly announces the successful closure of a monumental $165 million Series D financing round. Koch Disruptive Technologies spearheaded this investment, marking the largest private funding initiative in employer health benefits this year. Joining forces with existing investors such as GreatPoint Ventures, BOND, and…

Read More